






A patient names a compound you have heard of twice, and you have forty seconds before your silence becomes the answer.
You say you would rather not. She is gracious about it and she never comes back. Not for this, not for anything.
You know the clinic she went to. You are fairly sure nobody there has read a paper on it.
A patient names a compound you have heard of twice, and you have forty seconds before your silence becomes the answer.
You looked at the training. Most of it is three hours of video from someone with an affiliate link.
So you read the papers yourself at half past ten at night, and you find twelve rats and no control group, and you are no further forward.


Say yes, and it is reasoned and documented before she leaves.
Say no, and she does not leave either.





What this course is, what it is not, and an honest map of where the field stands today. All five lessons are free to watch.

How peptides work, how the body handles them, and how they are actually given. Includes a free lesson and downloadable reference material.

How to tell a real signal from a convincing one. Mechanism is not outcome. Includes a free lesson and downloadable reference material.

The hormone systems these compounds act on: growth, stress, sleep, reproduction. Includes downloadable reference material.

Medicinal claims, unlicensed medicines, consent, documentation, and when to decline. Includes a free lesson.

BPC-157, TB-500, GHK-Cu, KPV. What the evidence supports, and the malignancy question. Includes a free lesson and an evidence summary table.

GHRH analogues and GHRPs. Monitoring, risks, and when not to use. Includes Clinical Case 1.

MOTS-C, SS-31, NAD+. Where the energy claims outrun the evidence. Includes a free lesson.

Thymosin Alpha-1, LL-37, KPV. Autoimmune risk, and the myths. Includes Clinical Case 2.

Semax, Selank, ARA-290, Dihexa. Psychiatric considerations. Clinical Case 3, which is free to watch.

DSIP, Pinealon, Epithalon. Longevity claims measured against the evidence.

GLP-1 physiology, semaglutide, tirzepatide, retatrutide, orforglipron. Patient selection, side effects, microdosing, maintenance, lean mass preservation. Includes Clinical Case 4, and a preview of Healand's own retrospective study on lower-dose GLP-1 pathways, presented as the work in progress it is.

PT-141, kisspeptin, fertility considerations, and when to refer. Includes Clinical Case 5.

Final MCQ exam, written case reflection, and what comes next.
Almost every compound module ends in a risk, a myth, a when not to use, or a when to refer.
That is deliberate. This is a programme built to teach you when to say no.
A clinician who only knows when to say yes is not safer than they were last year.
Almost every compound module ends in a risk, a myth, a when not to use, or a when to refer.
That is deliberate. This is a programme built to teach you when to say no.
A clinician who only knows when to say yes is not safer than they were last year.
Six months of access from the day you enrol. Any major update released in that window is included. Subtitled, self-paced, works on a phone.
All of Module 1
Peptide biology explained simply
Mechanism is not Clinical Outcome
Unlicensed Medicines Explained
BPC-157
MOTS-C
Clinical Case 3: Cognitive Enhancement






Healand Peptide Masterclass - £999
Healand Weight Management Masterclass - £699
Clinical Support Access, 3 months - £147
Certificate of completion - Included
101 lessons (under £10/lesson)
3 months faculty access
$1,299 USD for international
Not an accreditation, and not a licence to practise peptide medicine.
Finishing it does not authorise you to prescribe anything.
No guarantee of patient outcomes, income or business results.
Not CPD-accredited. There are no CPD points attached to the course at present.
Not every peptide taught here is proven, routinely recommended, or legally available where you practise. Several are not, and the lessons name them.
You remain responsible for your own scope of practice and your own regulator's requirements.
For information and learning purposes only. It is not an accreditation. Exploring your own country's regulations is highly advised.
The science, the appraisal and the five questions are identical wherever you work. The governance module is written from the UK framework and we say so rather than hiding it. The reasoning travels. The local rules stay yours.
No, and be suspicious of anything that does. It teaches a structured approach: the patient's goals, their phenotype, the strength of the evidence, the alternatives, the exclusions, what to monitor, and when deferring or referring is the better decision. That is the five questions again.
No. The science, the appraisal, the monitoring and the governance apply whether you prescribe or not. Completing the course changes nothing about your prescribing authority or your scope.
Modules 1 to 5 are the part that changes how you answer patients. Start there. The compound modules are reference; you go to them on the afternoon a patient names one. Six months runs from the day you enrol, and any major update released in that window is included.
Instalment options will be available at checkout.
No, and be suspicious of anything that does. It teaches a structured approach: the patient's goals, their phenotype, the strength of the evidence, the alternatives, the exclusions, what to monitor, and when deferring or referring is the better decision. That is the five questions again.
Yes. Dosing principles, schedules and titration, always inside evidence, patient selection, tolerability and monitoring. Hands-on dose selection in simulated consultations is Tier 2, the in-person day, which assumes you have done this first.
Yes, about the course material. Not about your patients. Clinical Support is education, not supervision, and it would be irresponsible to pretend otherwise.
